human papillomavirus 16 E7 peptide

BIOLOGICAL3 trials

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC, Steward St. Elizabeth's Medical Center of Boston, Inc., National Cancer Institute (NCI)

Conditions

Anal CancerCervical CancerEsophageal CancerHead and Neck CancerPenile CancerVulvar Cancer

Phase 1

Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer

CompletedNCT00003977

Steward St. Elizabeth's Medical Center of Boston, Inc.Cervical Cancer

Start: 1999-11-30Updated: 2009-02-09

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

CompletedNCT00019110

National Cancer Institute (NCI)Anal Cancer, Cervical Cancer, Esophageal Cancer +3

Start: 1995-11-30Updated: 2015-04-29

Phase 2

Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

CompletedNCT00002916

European Organisation for Research and Treatment of Cancer - EORTCCervical Cancer

Start: 1996-11-30Target: 44Updated: 2012-07-02

Related Papers

Results disclosure of papilloma vaccine studies in humans completed before January 1st, 2011.

Figshare2014-01-01

Results disclosure of papilloma vaccine studies in humans co.

Figshare2014-01-01